High Cytotoxic Efficiency of Lentivirally and Alpharetrovirally Engineered CD19-Specific Chimeric Antigen Receptor Natural Killer Cells Against Acute Lymphoblastic Leukemia
Stephan Müller(Goethe University Frankfurt), Evelyn Ullrich(Goethe University Frankfurt), Eva Stolzenberg(Goethe University Frankfurt), Axel Schambach(Boston Children's Hospital), Ute Modlich(Swiss Institute for Regenerative Medicine), Winfried S. Wels(Goethe University Frankfurt), Tobias Bexte(Goethe University Frankfurt), Franziska Kalensee(University Hospital Frankfurt), Jessica Hartmann(Orygen), Veronika Gebel(Goethe University Frankfurt), Ulrike Koehl(Leipzig University)
Cited by 111
Related Papers
Lentiviral Vector Design and Imaging Approaches to Visualize the Early Stages of Cellular Reprogramming
|Molecular Therapy|2011|263
CRISPR-Cas9 based gene editing of the immune checkpoint NKG2A enhances NK cell mediated cytotoxicity against multiple myeloma
|OncoImmunology|2022|77
CRISPR/Cas9 editing of NKG2A improves the efficacy of primary CD33-directed chimeric antigen receptor natural killer cells
|Nature Communications|2024|71
The hemogenic endothelium: a critical source for the generation of PSC-derived hematopoietic stem and progenitor cells
|Cellular and Molecular Life Sciences|2021|54